Sorrento Therapeutics Rising Again To Recover Mid May’s Position

One of the most prominent COVID-19 vaccine creators Sorrento Therapeutics soared by breaking the $6 barrier on May 15. Then triumph was over temporarily until today’s pre-market activity. At least a 10% positive change just happened on stock tracking platforms.

If three COVID-19 programs: COVI-GUARD, COVI-SHIELD, and COVIDTRAP deliver satisfactory results NASDAQ: SRNE will rise by minimum 5-fold. Investors will be hovering over the stock by asking, “is it too late to join this hype?”. As the pandemic didn’t bring the second wave yet philanthropist hearted investors may risk anyway. If no results they will help. If successful they will help and make a huge fortune.

Alex Krakowsky

Editor in Chief. Living in the era of dynamic tech change Alex decided to stay tuned in changes that make any person find comfort and adapt to new devices. Furthermore, gaming became his passion for spending leisure time with his close ones. Although, he has a degree in Business Administration (majoring in Finance) writing for technology and as well as finance has been one of the precious aspects of his life